A clinical study on the efficacy of Hingvashtaka churna and Shalparnyadi kwatha in altered bowel habits of adults with Irritable Bowel Syndrome

A Single Arm Clinical Study To Evaluate The Efficacy Of Hingvashtakchurna and Shalparnyadikwatha In Irritable Bowel Syndrome With Special Reference To Vatikagrahani - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100183

Enrollment

Registered

2026-01-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients irrespective of sex and socio- economic status. 2.Patients having signs and symptoms (abdominal pain and altered bowel habits) of Irritable Bowel Syndrome and Vatika Grahani like Feeling of incomplete evacuation, constipation or diarrhoea or both,Bloating,Weakness

Exclusion criteria

Exclusion criteria: 1. Mixed infection with parasites like round worms, hook worms etc. 2. Patients with bleeding per rectum. 3. Patients with evidence of malignancy. 4. Patients having uncontrolled hypertension, diabetes mellitus type II; Amoebic dysentery, Malabsorption syndrome, Inflammatory Bowel Diseases & Intestinal tuberculosis, Lactase deficiency diarrhoea. 5. Patients suffering from major systemic illness like cancer, renal failure etc. 6. Patients who are taking corticosteroids, antidepressants, anticholinergic, or any other drugs that may have an influence on the outcome of study. 7. Alcoholics and drug abusers. 8. Pregnant and lactating women. 9. Patients who have completed participation in any other clinical trial during the past six months

Design outcomes

Primary

Measure	Time frame
Changes in the intensity of abdominal pain and altered bowel habits.Timepoint: At baseline and end of 4 weeks	—

Secondary

Measure	Time frame
Changes in the other symptoms (Bloating & Weakness) of IBS. Changes in quality of life. (IBS QOL 34 Questionnaire)Timepoint: At baseline, end of 4 weeks	—

Countries

India

Contacts

Public ContactDr Rashmi Mutha

National Institute of Ayurveda,Jaipur

rashmimutha21@yahoo.com9413102151

Outcome results